US Stock MarketDetailed Quotes
BLAC Bellevue Life Sciences Acquisition
- 11.530
- +0.250+2.22%
Close Dec 27 16:00 ET
46.60MMarket Cap-97.71P/E (TTM)
11.530High11.290Low1.20KVolume11.290Open11.280Pre Close13.60KTurnover0.07%Turnover Ratio160.14P/E (Static)4.04MShares13.40052wk High3.12P/B20.53MFloat Cap10.50052wk Low--Dividend TTM1.78MShs Float13.400Historical High--Div YieldTTM2.13%Amplitude10.070Historical Low11.333Avg Price1Lot Size
About Bellevue Life Sciences Acquisition Company
Bellevue Life Sciences Acquisition Corp. is a blank check company. Its objectives are to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.
Company Profile
SymbolBLAC
Company NameBellevue Life Sciences Acquisition
Listing DateFeb 10, 2023
Founded2020
CEOMr. Kuk Hyoun Hwang
MarketNASDAQ
Employees2
Fiscal Year Ends12-31
Address10900 NE 4th Street,Suite 2300
CityBellevue
ProvinceWashington
CountryUnited States of America
Zip Code98004
Phone1-425-635-7700
Websitehttps://www.bellevuespac.com
Company Executives
- Name
- Position
- Salary
- Kuk Hyoun Hwang
- Chief Executive Officer and Director
- --
- David Jin Yoo
- Chief Financial Officer and Principal Accounting Officer
- --
- Jun Chul Whang
- Director
- --
- Phil Geon Lee
- Independent Director
- --
- Sang Hyun Kim
- Independent Director
- --
- Jin Whan Park
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data